Results 191 to 200 of about 703,442 (215)

Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia. [PDF]

Ther Adv Hematol
Nilsson MS, Martner A, Wennström L, Hansson M, Thorén FB, Hellstrand K.   +5 more
europepmc   +1 more source

Efficacy and Safety of Low-Dose Interleukin-2 Therapy in Systemic Lupus Erythematosus: A Systematic Review. [PDF]

Cureus
Akkur MA, Areeshi NA, Haqawi IY, AlHabji AA, Altaher AH, Jawkhab HA, Fageehi MM, Moafa AA, Ismael AI, Al Alhadi NA.   +9 more
europepmc   +1 more source

Decreased gene expression of interleukin 2 receptor subunit γ (CD132) in tissues of patients with Crohn's disease. [PDF]

World J Gastroenterol
Andreu-Ballester JC, Hurtado-Marcos C, García-Ballesteros C, Pérez-Griera J, Izquierdo F, Ollero D, Jiménez A, Gil-Borrás R, Llombart-Cussac A, López-Chuliá F, Cuéllar C.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease

Circulation Research, 2021

exaly  

Biology and therapeutic potential of interleukin-10

Journal of Experimental Medicine, 2020
Anne O'Garra, Margarida Saraiva, Paulo Vieira   +2 more
exaly  

Interleukin-22: Immunobiology and Pathology

Annual Review of Immunology, 2015
Jarrod Dudakov, Alan Hanash
exaly  

Signaling and Function of Interleukin-2 in T Lymphocytes

Annual Review of Immunology, 2018
Sarah Ross, Doreen Cantrell
exaly  

Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen

Circulation, 2012
Tom Thurén, Peter Libby, Brendan Everett   +2 more
exaly